Anticancer and Tubulin Polymerisation Inhibition Activity of Benzylidene Indanones and Process of Preparing the Same
    9.
    发明申请
    Anticancer and Tubulin Polymerisation Inhibition Activity of Benzylidene Indanones and Process of Preparing the Same 有权
    苯亚甲基内酰胺的抗癌和微管蛋白聚合抑制活性及其制备方法

    公开(公告)号:US20130079396A1

    公开(公告)日:2013-03-28

    申请号:US13623161

    申请日:2012-09-20

    摘要: The present invention relates to benzylidene indanones of general formula 1. The compounds exhibited tubulin polymerisation inhibition. A series of compounds 2-benzylidene 3-(3,4,5-trimethoxyphenyl) indanones having general formulae 1 were synthesized from gallic acid through a chemical process. 2-(3,4-Methylenedioxybenzylidine), 3-(3,4,5-trimethoxyphenyl), 4,5,6-trimethoxyindanone (8), a representative compound of this series possessing the molecular formulae C29H28O9, was synthesized from gallic acid and exhibits potent anticancer activity. Compound 8 was evaluated for acute oral activity in Swiss albino mice and found to be safe up to 300 mg/kg body weight. The anticancer activity of the compounds has been determined, in order to obtain new potent and cost effective molecules using an in vitro cytotoxicity assay.

    摘要翻译: 本发明涉及通式1的亚苄基茚满酮。该化合物表现出微管蛋白聚合抑制作用。 通过化学方法由没食子酸合成一系列化合物,具有通式1的2-亚苄基3-(3,4,5-三甲氧基苯基)茚满酮。 2-(3,4-亚甲基二氧基亚苄基),3-(3,4,5-三甲氧基苯基),4,5,6-三甲氧基茚满酮(8),具有分子式C29H28O9的该系列的代表性化合物,由没食子酸 并具有很强的抗癌活性。 评估化合物8在瑞士白化病小鼠中的急性口服活性,发现其安全性高达300mg / kg体重。 已经确定了化合物的抗癌活性,以便使用体外细胞毒性测定来获得新的有效和成本有效的分子。